159 related articles for article (PubMed ID: 16574043)
1. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane.
Taylor PW; Keenan MH
Curr Med Res Opin; 2006 Mar; 22(3):603-15. PubMed ID: 16574043
[TBL] [Abstract][Full Text] [Related]
2. Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?
Smith JC; Tarocco G; Merazzi F; Salzmann U
Curr Med Res Opin; 2006 Apr; 22(4):709-20. PubMed ID: 16684432
[TBL] [Abstract][Full Text] [Related]
3. Are we underdosing acne patients with generic isotretinoin?
Mutizwa MM; Sheinbein DM
Dermatol Online J; 2013 Jan; 19(1):12. PubMed ID: 23374954
[TBL] [Abstract][Full Text] [Related]
4. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
J Am Acad Dermatol; 2001 Aug; 45(2):196-207. PubMed ID: 11464180
[TBL] [Abstract][Full Text] [Related]
5. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
6. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®.
Gasser UE; Fischer A; Timmermans JP; Arnet I
BMC Pharmacol Toxicol; 2013 Apr; 14():24. PubMed ID: 23617953
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical quality of nine generic orlistat products compared with Xenical(r).
Taylor PW; Arnet I; Fischer A; Simpson IN
Obes Facts; 2010 Aug; 3(4):231-7. PubMed ID: 20823686
[TBL] [Abstract][Full Text] [Related]
9. Roche responds to 'new warnings on the use of isotretinoin (Roaccutane)'.
Ebrahim O; Bredenhann M
S Afr Med J; 1999 Jan; 89(1):16. PubMed ID: 10070397
[No Abstract] [Full Text] [Related]
10. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
Liu A; Yang DJ; Gerhardstein PC; Hsu S
J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
[TBL] [Abstract][Full Text] [Related]
11. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
Kaymak Y; Taner E; Taner Y
Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
[TBL] [Abstract][Full Text] [Related]
12. Accutane-exposed pregnancies--California, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin: state of the art treatment for acne vulgaris.
Ganceviciene R; Zouboulis CC
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S47-59. PubMed ID: 20482692
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin.
Lambert PA; Conway BR
J Chemother; 2003 Aug; 15(4):357-68. PubMed ID: 12962364
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmaceutical quality of eight generic ganciclovir injections in China and Cymevene.
Hong C; Wang J
J Chemother; 2018 Sep; 30(5):310-315. PubMed ID: 30843773
[TBL] [Abstract][Full Text] [Related]
16. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris.
Layton AM; Dreno B; Gollnick HP; Zouboulis CC
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):773-6. PubMed ID: 16898895
[TBL] [Abstract][Full Text] [Related]
17. Impurities in generic pharmaceutical development.
Kovaleski J; Kraut B; Mattiuz A; Giangiulio M; Brobst G; Cagno W; Kulkarni P; Rauch T
Adv Drug Deliv Rev; 2007 Jan; 59(1):56-63. PubMed ID: 17196702
[TBL] [Abstract][Full Text] [Related]
18. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
19. [The Medical Products Agency is following up Roaccutane to assure patients' safety].
Gerdén B; Sjölin-Forsberg G; Trolin I
Lakartidningen; 2003 Mar; 100(10):870. PubMed ID: 12680028
[No Abstract] [Full Text] [Related]
20. Analysis of purity profiles of generic lisinopril tablets marketed in Croatia.
Benković G; Sokolić M; Cudina B; Zulj RT; Tomić S
Coll Antropol; 2013 Jun; 37(2):601-6. PubMed ID: 23941010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]